[Clinical study of treatment nonalcoholic fatty liver with qianggan capsule].
OBJECTIVE
To investigate the therapeutic effect of Qianggan capsule on the treatment of nonalcoholic fatty liver.


METHODS
One hundred and twenty-two patients of nonalcoholic fatty liver were randomly divided into two groups, 64 patients in the treated group were treated by Qianggan capsule, 5 granule every time, twice per day and the 58 patients in control group were treated by tiopronin, 0. 2 gram every time, third per day with a therapeutic course of 3 months.


RESULTS
Serum levels of ALT and gamma-GT were decreased significantly after the treatment of Qianggan capsule (P <0.05). However, TG levels seemed decreased but have not significant difference after the treatment of Qianggan capsule. The serum level of ALT in control group decreased markedly after treatment (P < 0.05), but no obvious change was seen in gamma-GT and TG in control group after treatment. The total effective rate in the treated group was higher than those in the control group (79.69% vs 62.07%, P < 0.05).


CONCLUSIONS
Qianggan capsule is an effective recipe in treating nonalcoholic fatty liver.
Chen
Ze-Xiong
ZX
The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China. zexiong333@163.com
Zhang
Shi-Jun
SJ
Yun
Li-Rong
LR
D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D002214:Capsules; D004334:Drug Administration Schedule; D004365:Drugs, Chinese Herbal / Q000302:isolation & purification / Q000627:therapeutic use*; D005234:Fatty Liver / Q000097:blood / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010946:Plants, Medicinal / Q000737:chemistry*; D016896:Treatment Outcome; D014280:Triglycerides / Q000097:blood; D005723:gamma-Glutamyltransferase / Q000097:blood
D002214:Capsules; D004365:Drugs, Chinese Herbal; D014280:Triglycerides; D005723:gamma-Glutamyltransferase; D000410:Alanine Transaminase